Melissa Shinder, DPM
Primary Podiatric Medicine · Mount Laurel, NJNPI 1356606347
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Smith+Nephew at 32.6% of the total. Reporting peaked in 2021 at $755 and has fallen 57.7% since, to $319 in 2025.
Across 134 payments — averaging $24.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$1K
- Organogenesis Inc.$497
- Integra Lifesciences Corporation$285
- Stryker$260
- Johnson & Johnson$227
- Medical Device Business Services, Inc.$118
- plus $849 from 19 others
What the payments were for
- Food & beverage$3,316100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 59 | $1,080 |
| Organogenesis Inc. | 13 | $497 |
| Integra Lifesciences Corporation | 10 | $285 |
| Stryker | 4 | $260 |
| Johnson & Johnson | 4 | $227 |
| Medical Device Business Services, Inc. | 1 | $118 |
| Bioventus LLC | 3 | $93 |
| Medline Industries LP | 4 | $87 |
| KCI USA, Inc. | 4 | $82 |
| Misonix Inc | 6 | $79 |
| AbbVie | 3 | $72 |
| Paratek Pharmaceuticals, Inc. | 5 | $71 |
| Zimmer Biomet | 3 | $61 |
| Next Science LLC | 2 | $55 |
| Hartmann USA, Inc. | 2 | $48 |
| Lifenet Health | 2 | $38 |
| Solventum Corporation | 1 | $32 |
| Kerecis Limited | 1 | $25 |
| Acera Surgical, Inc. | 1 | $22 |
| Orthofix Medical, Inc. | 1 | $16 |
| Urgo Medical North America, LLC | 1 | $16 |
| Biotissue Holdings Inc. | 1 | $15 |
| Amgen | 1 | $13 |
| Heron Therapeutics, Inc. | 1 | $13 |
| Paragon 28, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BILAYER WOUND MATRIX (BWM)$158
- INTEGRA WOUND MATRIX (IWM)$158
- AMNIOEXCEL$158
- IDRT$158
- FLOWABLE$158
- GRAFIX PL$147
- Oasis$147
- Stravix$147
- PuraPly$125
- Fibulink$121
- BIO4$100
- SONICANCHOR$100
- NEUROMEND$100
How this compares
$3,316 in reported general payments places this provider in the 85th percentile of 45 primary podiatric medicine providers in New Jersey.
See all primary podiatric medicine providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 28 | $56,836 |
| CiclopiroxCiclopirox Olamine | 168 | $2,826 |
| Ammonium Lactate | 58 | $1,118 |
| Doxycycline Monohydrate | 24 | $436 |
| Ketoconazole | 16 | $394 |
| Methylprednisolone | 44 | $323 |
| Gabapentin | 38 | $291 |
| Betamethasone Dipropionate | 14 | $239 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $185 |
| Cephalexin | 13 | $98 |
| Prednisone | 13 | $66 |
| Tramadol Hcl | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $1,080 | $56,83628 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 45 primary podiatric medicine providers in New Jersey.
Other primary podiatric medicine in Mount Laurel
- Andrew BloomEnglewood$14K
- Paul KleinWayne$6K
- Jessica AddeoHowell$5K
- Alicia LaiLinwood$5K
- Adenike SonaikeFair Lawn$5K
- Harvey KarpoWoodbury$5K
- Richard MunozDover$3K
- Stephanie ExleyWoodbury$2K
- Richard FilipekGarfield$2K
- Robert TyrrellCherry Hill$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.